The WNT Framework in Shaping Immune Cell Responses During Bacterial Infections
Overview
Affiliations
A large proportion of the world is inflicted with health concerns arising from infectious diseases. Moreover, there is a widespread emergence of antibiotic resistance among major infectious agents, partially stemming from their continuous dialog with the host, and their enormous capacity to remodel the latter toward a secure niche. Among the several infection-driven events, moderation of WNT signaling pathway has been identified to be strategically tuned during infections to govern host-pathogen interactions. Primarily known for its role in arbitrating early embryonic developmental events; aberrant activation of the WNT pathway has also been associated with immunological consequences during diverse patho-physiological conditions. Here, we review the different mechanisms by which components of WNT signaling pathways are exploited by discrete bacterial agents for their pathogenesis. Furthermore, recent advances on the cross-talk of WNT with other signaling pathways, the varied modes of WNT-mediated alteration of gene expression, and WNT-dependent post-transcriptional and post-translational regulation of the immune landscape during distinct bacterial infections would be highlighted.
Cell signaling in infection and cancer: Parallels in pathogenesis.
Solomon R, Pittner N, McCoy J, Warwick P, McBride J Front Cell Infect Microbiol. 2025; 15:1539847.
PMID: 40028182 PMC: 11868041. DOI: 10.3389/fcimb.2025.1539847.
Prakhar P, Bhatt B, Lohia G, Shah A, Mukherjee T, Kolthur-Seetharam U PLoS Pathog. 2023; 19(10):e1011731.
PMID: 37871034 PMC: 10621959. DOI: 10.1371/journal.ppat.1011731.
Sharma S, Kumar M, Kumar J, Mazumder S Cells. 2023; 12(11).
PMID: 37296630 PMC: 10252323. DOI: 10.3390/cells12111509.
Xiong Y, Xu Y, Zhou F, Hu Y, Zhao J, Liu Z Bioeng Transl Med. 2023; 8(1):e10373.
PMID: 36684072 PMC: 9842067. DOI: 10.1002/btm2.10373.
The functional roles of the circRNA/Wnt axis in cancer.
Xue C, Li G, Zheng Q, Gu X, Bao Z, Lu J Mol Cancer. 2022; 21(1):108.
PMID: 35513849 PMC: 9074313. DOI: 10.1186/s12943-022-01582-0.